KRINGLE PHARMA INCKK

KRINGLE PHARMA INC

962JPYD
−46−4.56%
At close at 06:25 GMT
JPY
No trades
See on Supercharts

4884 fundamentals

KRINGLE PHARMA INC revenue breakdown overview

KRINGLE PHARMA INC revenue for the last year amounted to 80.00 M JPY, the most of which — 73.84 M JPY — came from its highest performing source at the moment, Royalty, the year earlier bringing 69.25 M JPY. The greatest contribution to the revenue figure was made by United States — last year it brought KRINGLE PHARMA INC 80.04 M JPY, and the year before that — 69.25 M JPY.

By source
2020
2021
2022
2023
2024
‪0.00‬
‪‪120.00 M‬‬
‪‪240.00 M‬‬
‪‪360.00 M‬‬
‪‪480.00 M‬‬
Royalty
Drug Development
Currency: JPY
2020
2021
2022
2023
2024
Royalty
‪‪56.18 M‬‬
‪‪69.25 M‬‬
‪‪73.84 M‬‬
Drug Development
‪‪467.62 M‬‬
‪‪289.76 M‬‬
‪‪335.64 M‬‬
‪‪6.20 M‬‬
By country
2020
2021
2022
2023
2024
‪0.00‬
‪‪120.00 M‬‬
‪‪240.00 M‬‬
‪‪360.00 M‬‬
‪‪480.00 M‬‬
United States
Japan
Currency: JPY
2020
2021
2022
2023
2024
United States
‪‪167.62 M‬‬
‪‪289.76 M‬‬
‪‪391.83 M‬‬
‪‪69.25 M‬‬
‪‪80.04 M‬‬
Japan
‪‪300.00 M‬‬